295 related articles for article (PubMed ID: 29550548)
21. LRRK2 G2019S and Parkinson's disease: insight from Neuroinflammation.
Yao XY; Guan LN; Chen Q; Ren C
Postgrad Med J; 2023 Dec; 100(1179):4-11. PubMed ID: 37777187
[TBL] [Abstract][Full Text] [Related]
22. Targeting the cannabinoid CB2 receptor to attenuate the progression of motor deficits in LRRK2-transgenic mice.
Palomo-Garo C; Gómez-Gálvez Y; García C; Fernández-Ruiz J
Pharmacol Res; 2016 Aug; 110():181-192. PubMed ID: 27063942
[TBL] [Abstract][Full Text] [Related]
23. Mutations in LRRK2 impair NF-κB pathway in iPSC-derived neurons.
López de Maturana R; Lang V; Zubiarrain A; Sousa A; Vázquez N; Gorostidi A; Águila J; López de Munain A; Rodríguez M; Sánchez-Pernaute R
J Neuroinflammation; 2016 Nov; 13(1):295. PubMed ID: 27863501
[TBL] [Abstract][Full Text] [Related]
24. Nigrostriatal pathology with reduced astrocytes in LRRK2 S910/S935 phosphorylation deficient knockin mice.
Zhao Y; Keshiya S; Atashrazm F; Gao J; Ittner LM; Alessi DR; Halliday GM; Fu Y; Dzamko N
Neurobiol Dis; 2018 Dec; 120():76-87. PubMed ID: 30194047
[TBL] [Abstract][Full Text] [Related]
25. G2019S LRRK2 enhances the neuronal transmission of tau in the mouse brain.
Nguyen APT; Daniel G; Valdés P; Islam MS; Schneider BL; Moore DJ
Hum Mol Genet; 2018 Jan; 27(1):120-134. PubMed ID: 29088368
[TBL] [Abstract][Full Text] [Related]
26. The impact of murine LRRK2 G2019S transgene overexpression on acute responses to inflammatory challenge.
Litteljohn D; Rudyk C; Dwyer Z; Farmer K; Fortin T; Hayley S;
Brain Behav Immun; 2018 Jan; 67():246-256. PubMed ID: 28893563
[TBL] [Abstract][Full Text] [Related]
27. Overexpression of Parkinson's Disease-Associated Mutation LRRK2 G2019S in Mouse Forebrain Induces Behavioral Deficits and α-Synuclein Pathology.
Xiong Y; Neifert S; Karuppagounder SS; Stankowski JN; Lee BD; Grima JC; Chen G; Ko HS; Lee Y; Swing D; Tessarollo L; Dawson TM; Dawson VL
eNeuro; 2017; 4(2):. PubMed ID: 28321439
[TBL] [Abstract][Full Text] [Related]
28. R1441C and G2019S LRRK2 knockin mice have distinct striatal molecular, physiological, and behavioral alterations.
Xenias HS; Chen C; Kang S; Cherian S; Situ X; Shanmugasundaram B; Liu G; Scesa G; Savio Chan C; Parisiadou L
Commun Biol; 2022 Nov; 5(1):1211. PubMed ID: 36357506
[TBL] [Abstract][Full Text] [Related]
29. Chronic and acute LRRK2 silencing has no long-term behavioral effects, whereas wild-type and mutant LRRK2 overexpression induce motor and cognitive deficits and altered regulation of dopamine release.
Volta M; Cataldi S; Beccano-Kelly D; Munsie L; Tatarnikov I; Chou P; Bergeron S; Mitchell E; Lim R; Khinda J; Lloret A; Bennett CF; Paradiso C; Morari M; Farrer MJ; Milnerwood AJ
Parkinsonism Relat Disord; 2015 Oct; 21(10):1156-63. PubMed ID: 26282470
[TBL] [Abstract][Full Text] [Related]
30. Dysregulated phosphorylation of Rab GTPases by LRRK2 induces neurodegeneration.
Jeong GR; Jang EH; Bae JR; Jun S; Kang HC; Park CH; Shin JH; Yamamoto Y; Tanaka-Yamamoto K; Dawson VL; Dawson TM; Hur EM; Lee BD
Mol Neurodegener; 2018 Feb; 13(1):8. PubMed ID: 29439717
[TBL] [Abstract][Full Text] [Related]
31. Mild Chronic Colitis Triggers Parkinsonism in LRRK2 Mutant Mice Through Activating TNF-α Pathway.
Lin CH; Lin HY; Ho EP; Ke YC; Cheng MF; Shiue CY; Wu CH; Liao PH; Hsu AY; Chu LA; Liu YD; Lin YH; Tai YC; Shun CT; Chiu HM; Wu MS
Mov Disord; 2022 Apr; 37(4):745-757. PubMed ID: 34918781
[TBL] [Abstract][Full Text] [Related]
32. LRRK2 impairs autophagy by mediating phosphorylation of leucyl-tRNA synthetase.
Ho DH; Kim H; Nam D; Sim H; Kim J; Kim HG; Son I; Seol W
Cell Biochem Funct; 2018 Dec; 36(8):431-442. PubMed ID: 30411383
[TBL] [Abstract][Full Text] [Related]
33. The C-terminal domain of LRRK2 with the G2019S mutation is sufficient to produce neurodegeneration of dopaminergic neurons in vivo.
Cresto N; Gaillard MC; Gardier C; Gubinelli F; Diguet E; Bellet D; Legroux L; Mitja J; Auregan G; Guillermier M; Josephine C; Jan C; Dufour N; Joliot A; Hantraye P; Bonvento G; Déglon N; Bemelmans AP; Cambon K; Liot G; Brouillet E
Neurobiol Dis; 2020 Feb; 134():104614. PubMed ID: 31605779
[TBL] [Abstract][Full Text] [Related]
34. The pathogenic LRRK2 R1441C mutation induces specific deficits modeling the prodromal phase of Parkinson's disease in the mouse.
Giesert F; Glasl L; Zimprich A; Ernst L; Piccoli G; Stautner C; Zerle J; Hölter SM; Vogt Weisenhorn DM; Wurst W
Neurobiol Dis; 2017 Sep; 105():179-193. PubMed ID: 28576705
[TBL] [Abstract][Full Text] [Related]
35. Mutations in LRRK2 linked to Parkinson disease sequester Rab8a to damaged lysosomes and regulate transferrin-mediated iron uptake in microglia.
Mamais A; Kluss JH; Bonet-Ponce L; Landeck N; Langston RG; Smith N; Beilina A; Kaganovich A; Ghosh MC; Pellegrini L; Kumaran R; Papazoglou I; Heaton GR; Bandopadhyay R; Maio N; Kim C; LaVoie MJ; Gershlick DC; Cookson MR
PLoS Biol; 2021 Dec; 19(12):e3001480. PubMed ID: 34914695
[TBL] [Abstract][Full Text] [Related]
36. LRRK2 G2019S Induces Anxiety/Depression-like Behavior before the Onset of Motor Dysfunction with 5-HT
Lim J; Bang Y; Choi JH; Han A; Kwon MS; Liu KH; Choi HJ
J Neurosci; 2018 Feb; 38(7):1611-1621. PubMed ID: 29305532
[TBL] [Abstract][Full Text] [Related]
37. Effects of LRRK2 Inhibitors on Nigrostriatal Dopaminergic Neurotransmission.
Qin Q; Zhi LT; Li XT; Yue ZY; Li GZ; Zhang H
CNS Neurosci Ther; 2017 Feb; 23(2):162-173. PubMed ID: 27943591
[TBL] [Abstract][Full Text] [Related]
38. LRRK2 inhibition does not impart protection from α-synuclein pathology and neuron death in non-transgenic mice.
Henderson MX; Sengupta M; McGeary I; Zhang B; Olufemi MF; Brown H; Trojanowski JQ; Lee VMY
Acta Neuropathol Commun; 2019 Feb; 7(1):28. PubMed ID: 30808409
[TBL] [Abstract][Full Text] [Related]
39. Leucine-rich repeat kinase 2-related functions in GLIA: an update of the last years.
Filippini A; Gennarelli M; Russo I
Biochem Soc Trans; 2021 Jun; 49(3):1375-1384. PubMed ID: 33960369
[TBL] [Abstract][Full Text] [Related]
40. Lack of exacerbation of neurodegeneration in a double transgenic mouse model of mutant LRRK2 and tau.
Mikhail F; Calingasan N; Parolari L; Subramanian A; Yang L; Flint Beal M
Hum Mol Genet; 2015 Jun; 24(12):3545-56. PubMed ID: 25804954
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
